Dietary antioxidant trans-cinnamaldehyde reduced visfatin-induced breast cancer progression: In vivo and in vitro study

Yi Fen Chiang, Hsin Yuan Chen, Ko Chieh Huang, Po Han Lin, Shih Min Hsia

研究成果: 雜誌貢獻文章

摘要

Excessive growth of cancer cells is the main cause of cancer mortality. Therefore, discovering how to inhibit cancer growth is an important research topic. Recently, the newly discovered adipokine, known as nicotinamide phosphoribosyl transferase (NAMPT, visfatin), which has been associated with metabolic syndrome and obesity, has also been found to be a major cause of cancer proliferation. Therefore, inhibition of NAMPT and reduction of Nicotinamide adenine dinucleotide (NAD) synthesis is one strategy for cancer therapy. Cinnamaldehyde (CA), as an antioxidant and anticancer natural compound, may have the ability to inhibit visfatin. The breast cancer cell line and xenograft animal models were treated under different dosages of visfatin combined with CA and FK866 (a visfatin inhibitor) to test for cell toxicity, as well as inhibition of tumor-related proliferation of protein expression. In the breast cancer cell and the xenograft animal model, visfatin significantly increased proliferation-related protein expression, but combination with CA or FK866 significantly reduced visfatin-induced carcinogenic effects. For the first time, a natural compound inhibiting extracellular and intracellular NAMPT has been demonstrated. We hope that, in the future, this can be used as a potential anticancer compound and provide further directions for research.
原文英語
文章編號625
期刊Antioxidants
8
發行號12
DOIs
出版狀態已發佈 - 十二月 2019

指紋

Nicotinamide Phosphoribosyltransferase
Antioxidants
Breast Neoplasms
Neoplasms
Cells
Heterografts
Animals
Animal Models
Toxicity Tests
Adipokines
Niacinamide
Growth
Transferases
Research
NAD
Toxicity
cinnamic aldehyde
In Vitro Techniques
Tumors
Proteins

ASJC Scopus subject areas

  • Biochemistry
  • Physiology
  • Molecular Biology
  • Clinical Biochemistry
  • Cell Biology

引用此文

Dietary antioxidant trans-cinnamaldehyde reduced visfatin-induced breast cancer progression : In vivo and in vitro study. / Chiang, Yi Fen; Chen, Hsin Yuan; Huang, Ko Chieh; Lin, Po Han; Hsia, Shih Min.

於: Antioxidants, 卷 8, 編號 12, 625, 12.2019.

研究成果: 雜誌貢獻文章

Chiang, Yi Fen ; Chen, Hsin Yuan ; Huang, Ko Chieh ; Lin, Po Han ; Hsia, Shih Min. / Dietary antioxidant trans-cinnamaldehyde reduced visfatin-induced breast cancer progression : In vivo and in vitro study. 於: Antioxidants. 2019 ; 卷 8, 編號 12.
@article{35e8f9ee197643e68bebf8adfe9122a7,
title = "Dietary antioxidant trans-cinnamaldehyde reduced visfatin-induced breast cancer progression: In vivo and in vitro study",
abstract = "Excessive growth of cancer cells is the main cause of cancer mortality. Therefore, discovering how to inhibit cancer growth is an important research topic. Recently, the newly discovered adipokine, known as nicotinamide phosphoribosyl transferase (NAMPT, visfatin), which has been associated with metabolic syndrome and obesity, has also been found to be a major cause of cancer proliferation. Therefore, inhibition of NAMPT and reduction of Nicotinamide adenine dinucleotide (NAD) synthesis is one strategy for cancer therapy. Cinnamaldehyde (CA), as an antioxidant and anticancer natural compound, may have the ability to inhibit visfatin. The breast cancer cell line and xenograft animal models were treated under different dosages of visfatin combined with CA and FK866 (a visfatin inhibitor) to test for cell toxicity, as well as inhibition of tumor-related proliferation of protein expression. In the breast cancer cell and the xenograft animal model, visfatin significantly increased proliferation-related protein expression, but combination with CA or FK866 significantly reduced visfatin-induced carcinogenic effects. For the first time, a natural compound inhibiting extracellular and intracellular NAMPT has been demonstrated. We hope that, in the future, this can be used as a potential anticancer compound and provide further directions for research.",
keywords = "Adipokine, Breast cancer, Cinnamaldehyde, Visfatin",
author = "Chiang, {Yi Fen} and Chen, {Hsin Yuan} and Huang, {Ko Chieh} and Lin, {Po Han} and Hsia, {Shih Min}",
year = "2019",
month = "12",
doi = "10.3390/antiox8120625",
language = "English",
volume = "8",
journal = "Antioxidants",
issn = "2076-3921",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "12",

}

TY - JOUR

T1 - Dietary antioxidant trans-cinnamaldehyde reduced visfatin-induced breast cancer progression

T2 - In vivo and in vitro study

AU - Chiang, Yi Fen

AU - Chen, Hsin Yuan

AU - Huang, Ko Chieh

AU - Lin, Po Han

AU - Hsia, Shih Min

PY - 2019/12

Y1 - 2019/12

N2 - Excessive growth of cancer cells is the main cause of cancer mortality. Therefore, discovering how to inhibit cancer growth is an important research topic. Recently, the newly discovered adipokine, known as nicotinamide phosphoribosyl transferase (NAMPT, visfatin), which has been associated with metabolic syndrome and obesity, has also been found to be a major cause of cancer proliferation. Therefore, inhibition of NAMPT and reduction of Nicotinamide adenine dinucleotide (NAD) synthesis is one strategy for cancer therapy. Cinnamaldehyde (CA), as an antioxidant and anticancer natural compound, may have the ability to inhibit visfatin. The breast cancer cell line and xenograft animal models were treated under different dosages of visfatin combined with CA and FK866 (a visfatin inhibitor) to test for cell toxicity, as well as inhibition of tumor-related proliferation of protein expression. In the breast cancer cell and the xenograft animal model, visfatin significantly increased proliferation-related protein expression, but combination with CA or FK866 significantly reduced visfatin-induced carcinogenic effects. For the first time, a natural compound inhibiting extracellular and intracellular NAMPT has been demonstrated. We hope that, in the future, this can be used as a potential anticancer compound and provide further directions for research.

AB - Excessive growth of cancer cells is the main cause of cancer mortality. Therefore, discovering how to inhibit cancer growth is an important research topic. Recently, the newly discovered adipokine, known as nicotinamide phosphoribosyl transferase (NAMPT, visfatin), which has been associated with metabolic syndrome and obesity, has also been found to be a major cause of cancer proliferation. Therefore, inhibition of NAMPT and reduction of Nicotinamide adenine dinucleotide (NAD) synthesis is one strategy for cancer therapy. Cinnamaldehyde (CA), as an antioxidant and anticancer natural compound, may have the ability to inhibit visfatin. The breast cancer cell line and xenograft animal models were treated under different dosages of visfatin combined with CA and FK866 (a visfatin inhibitor) to test for cell toxicity, as well as inhibition of tumor-related proliferation of protein expression. In the breast cancer cell and the xenograft animal model, visfatin significantly increased proliferation-related protein expression, but combination with CA or FK866 significantly reduced visfatin-induced carcinogenic effects. For the first time, a natural compound inhibiting extracellular and intracellular NAMPT has been demonstrated. We hope that, in the future, this can be used as a potential anticancer compound and provide further directions for research.

KW - Adipokine

KW - Breast cancer

KW - Cinnamaldehyde

KW - Visfatin

UR - http://www.scopus.com/inward/record.url?scp=85076263286&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85076263286&partnerID=8YFLogxK

U2 - 10.3390/antiox8120625

DO - 10.3390/antiox8120625

M3 - Article

AN - SCOPUS:85076263286

VL - 8

JO - Antioxidants

JF - Antioxidants

SN - 2076-3921

IS - 12

M1 - 625

ER -